These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 16218032
1. Clinical application of monitoring mycophenolic acid trough concentration in heart transplant recipients--single center's experience. Zakliczyński M, Szewczyk M, Zakliczyńska H, Zembala M. Ann Transplant; 2005; 10(2):38-45. PubMed ID: 16218032 [Abstract] [Full Text] [Related]
11. Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients. Mino Y, Naito T, Otsuka A, Ushiyama T, Ozono S, Kagawa Y, Kawakami J. Clin Biochem; 2009 May; 42(7-8):595-601. PubMed ID: 19100248 [Abstract] [Full Text] [Related]
15. Influence of metal cations on plasma trough concentration of mycophenolic Acid and its glucuronide in tacrolimus-treated and cyclosporine-treated kidney transplant recipients. Naito T, Mino Y, Otsuka A, Ushiyama T, Ozono S, Kagawa Y, Kawakami J. Biol Pharm Bull; 2008 Jun; 31(6):1292-6. PubMed ID: 18520072 [Abstract] [Full Text] [Related]
16. Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation. Naito T, Shinno K, Maeda T, Kagawa Y, Hashimoto H, Otsuka A, Takayama T, Ushiyama T, Suzuki K, Ozono S. Biol Pharm Bull; 2006 Feb; 29(2):275-80. PubMed ID: 16462031 [Abstract] [Full Text] [Related]
17. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant. Pawinski T, Durlik M, Szlaska I, Urbanowicz A, Majchrnak J, Gralak B. J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117 [Abstract] [Full Text] [Related]